Condition: Non-cystic Fibrosis Bronchiectasis · Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
This study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily via standard jet nebulizer over at least 24 weeks, compared to placebo, in subjects with non-cystic fibrosis bronchiectasis (NCFBE).
This description comes directly from the study's public registry record.
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway Toll Free Number · Reach out by phone or email · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Kirklin Clinic of UAB Hospital | Birmingham, Alabama, United States | Recruiting |
| So Cal Institute for Respiratory Diseases, Inc. | Los Angeles, California, United States | Recruiting |
| University of California Davis Medical Center | Sacramento, California, United States | Recruiting |
| National Jewish Health Main Campus | Denver, Colorado, United States | Recruiting |
| MedStar Georgetown University Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| Emory University at Saint Joseph Pulmonary Clinic | Atlanta, Georgia, United States | Recruiting |
| Augusta University | Augusta, Georgia, United States | Recruiting |
| ASHA Clinical Research | Hammond, Indiana, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| University of Kansas Medical Center-Kansas City | Kansas City, Kansas, United States | Recruiting |
| Massachusetts General Hospital- 55 Fruit St | Boston, Massachusetts, United States | Recruiting |
+ 39 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06559150